Notice: Prescription Drug List (PDL): Multiple additions (2020-07-15)

The purpose of this Notice of Amendment is to notify about the additions of Alpelisib, Baloxavir marboxil, Betula verrucosa (white birch), Brolucizumab, Cabotegravir, Caplacizumab, Ciclesonide, Darolutamide, Entrectinib, Fremanezumab, Glasdegib, Isatuximab, Siponimod, Tenapanor, Tetracosactide and Tucatinib to the Prescription Drug List (PDL) for human and/or veterinary use.